General Health

General health issues, Medical conditions, Research and studies and more

Mental Health

Natural Medicine

Nutritional supplements, Herbs, Alternative medicine and more…

Wellness & Lifestyle

Nutrition, Diets, Healthy living, Detox, Exercise and Physical Fitness, Sports Fitness and more…

Women’s Health

Relationships, Pregnancy, Birth control, Menopause and more

Home » Information, News

FDA to Monitor Breast Implants for Cancer Risk

Article / Review by on January 31, 2011 – 8:25 pmNo Comments

FDA to Monitor Breast Implants for Cancer Risk

FDA to Monitor Breast Implants for Cancer Risk

Last week, U.S. health officials announced plans to investigate a possible association between breast implants and anaplastic large cell lymphoma – a rare but treatable cancer.

According to the FDA, the cancer risk – if it exists – is very small. Five to 10 million women have received implants in the past decade, and only 60 cases of the cancer have been reported worldwide (34 documented in medical literature).

We spoke to URMC’s Chief of Plastic Surgery Dr. Howard Langstein (he performs more than 75 breast implant surgeries a year, both for patients seeking augmentation, and for those seeking reconstruction after cancer — e.g., after mastectomy) to see how patients should interpret the news.

Dr. Langstein warns that women with implants need not worry, undergo tests or have implants removed if they are not having problems.  Rather, they should simply continue to conduct routine breast self-exams.

To hear Dr. Langstein make more sense of the FDA announcement, watch the clip below.

###

*  The above story is adapted from materials provided by University of Rochester Medical Center

______________________________________________________________________

University of Rochester Medical Center

Tags: ,

Leave a comment!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Notify me of followup comments via e-mail. You can also subscribe without commenting.